Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Use should be discontinued upon observing any adverse reaction
Regulatory and legal status FDA classification As of April 2026, BPC-157 is a Category 2 bulk drug substance under FDA's framework for compounding under Section 503A
Always do your research to ensure youre buying a safe product, only purchase supplements that have been certified by NSF International or USP, and speak to your doctor first
Patients who should not receive BPC-157 include: those with active or recent malignancies (due to angiogenic concerns), pregnant or breastfeeding women (no reproductive toxicology data in humans), patients on anticoagulation therapy (theoretical bleeding risk from angiogenesis at ulcer sites), and minors (no pediatric data of any kind)
US$ 28.31
US$ 21.75
US$ 26.22
US$ 26.24
